[Immune modulation in multiple sclerosis: linomide].
Weilbach
E X
EX
Klinische Forschungsgruppe für Multiple Sklerose, Julius-Maximilians-Universität, Würzburg.
Hartung
H P
HP
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006912:Hydroxyquinolines / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic; D006912:Hydroxyquinolines; C045282:roquinimex